Histiocytic sarcoma: review, discussion of transformation from B-cell lymphoma, and differential diagnosis
SL Skala, DR Lucas, R Dewar - Archives of pathology & …, 2018 - meridian.allenpress.com
Context.—Histiocytic sarcoma is a rare neoplasm of mature histiocytes with an aggressive
clinical course that can arise de novo or from a low-grade B-cell lymphoma. In particular …
clinical course that can arise de novo or from a low-grade B-cell lymphoma. In particular …
[HTML][HTML] Progression in myeloid neoplasms: beyond the myeloblast
C Faria, A Tzankov - Pathobiology, 2024 - karger.com
Disease progression in myelodysplastic syndromes (MDS), myelodysplastic-
myeloproliferative neoplasms (MDS/MPN), and myeloproliferative neoplasms (MPN) …
myeloproliferative neoplasms (MDS/MPN), and myeloproliferative neoplasms (MPN) …
[HTML][HTML] Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma
V Shanmugam, GK Griffin, ED Jacobsen… - Modern Pathology, 2019 - Elsevier
Recent studies have demonstrated recurrent activating mutations involving the classical
MAPK and PI3K signaling pathways in a large proportion of histiocytic neoplasms, such as …
MAPK and PI3K signaling pathways in a large proportion of histiocytic neoplasms, such as …
[HTML][HTML] Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups
C Egan, A Nicolae, J Lack, HJ Chung… - …, 2020 - ncbi.nlm.nih.gov
Histiocytic sarcoma is a rare malignant neoplasm that may occur de novo or in the context of
a previous hematologic malignancy or mediastinal germ cell tumor. Here, we performed …
a previous hematologic malignancy or mediastinal germ cell tumor. Here, we performed …
Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases
Tumors derived from histiocytic and dendritic cells encompass a large and heterogeneous
group of neoplastic and reactive conditions, and their diagnosis is challenging both for …
group of neoplastic and reactive conditions, and their diagnosis is challenging both for …
Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for …
The bone marrow is a preferential site for both reactive and neoplastic histiocytic
proliferations. The differential diagnosis ranges from reactive histiocyte hyperplasia in …
proliferations. The differential diagnosis ranges from reactive histiocyte hyperplasia in …
Increased tumor-infiltrating lymphocyte density is associated with favorable outcomes in a comparative study of canine histiocytic sarcoma
JA Lenz, CA Assenmacher, V Costa, K Louka… - Cancer Immunology …, 2022 - Springer
Histiocytic sarcoma (HS) is a rare and aggressive tumor in humans with no universally
agreed standard of care therapy. Spontaneous canine HS exhibits increased prevalence in …
agreed standard of care therapy. Spontaneous canine HS exhibits increased prevalence in …
Gain‐of‐function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs
T Thaiwong, S Sirivisoot, M Takada… - Veterinary and …, 2018 - Wiley Online Library
Histiocytic sarcoma (HS) is an aggressive malignant neoplasm of dendritic cell origin that is
common in certain breeds of dogs. High prevalence of fatal, disseminated HS has been …
common in certain breeds of dogs. High prevalence of fatal, disseminated HS has been …
Application of PD‑L1 blockade in refractory histiocytic sarcoma: A case report
O Imataki, M Uemura, H Fujita… - Molecular and …, 2022 - spandidos-publications.com
Histiocytic sarcoma (HS) is a rare hematological malignancy, which exhibits morphological
and immunophenotypic features of histiocytes. A standard therapy for HS has not yet been …
and immunophenotypic features of histiocytes. A standard therapy for HS has not yet been …
[HTML][HTML] High frequency of clonal IG and T-cell receptor gene rearrangements in histiocytic and dendritic cell neoplasms
W Huang, T Qiu, L Zeng, B Zheng, J Ying, X Feng - Oncotarget, 2016 - ncbi.nlm.nih.gov
Abstract The 2008 World Health Organization (WHO) diagnostic criteria of histiocytic and
dendritic cell neoplasms from hematopoietic and lymphoid tissues no longer required the …
dendritic cell neoplasms from hematopoietic and lymphoid tissues no longer required the …